羌活产业现状及发展对策

发布时间：2018-06-11 22:08

  本文选题：羌活药材 + 羌活　； 参考：《中国中药杂志》2017年14期

【摘要】：羌活作为一种重要传统中药品种,目前为694个药厂生产的262种中成药原料,在整个中医药产业中具有显著经济价值和社会价值,但其野生资源濒危且尚未完全实现人工产业化栽培。该文在系统总结羌活药材的用药历史与产业发展现状分析的基础上,系统阐述了羌活药材资源分布、羌活生态适宜性、羌活种子生产、种苗繁育、规模化栽培等产业化栽培的相关内容,并提出实施羌活产业化过程中需关注的关键问题及对策。
[Abstract]:As an important traditional Chinese medicine variety, Notopterygium Notopterygii has 262 kinds of raw materials of Chinese patent medicine produced by 694 pharmaceutical factories, which have significant economic and social value in the whole Chinese medicine industry. But its wild resources are endangered and have not been fully cultivated. On the basis of systematically summarizing the history of drug use and the present situation of industry development of Radix Notopterygii, the distribution of medicinal materials, ecological suitability, seed production and seedling breeding of Notopterygium Notopterygii were systematically described in this paper. The related contents of industrialized cultivation such as large-scale cultivation were put forward, and the key problems and countermeasures to be paid attention to in the process of industrialization of Notopterygium chinensis were put forward.
【作者单位】： 四川省中医药科学院;四川大学环境科学与工程系;中国医学科学院北京协和医学院药用植物研究所;成都大学环境系;四川省中医药管理局;
【基金】：国家自然科学基金项目(81473311) 四川省中医药强省建设战略研究项目(2016ZR0068) 四川省中医药管理局科技专项(2017Z003)
【分类号】：F326.12;R288
，

本文编号：2006869